Workflow
Investment Strategy
icon
搜索文档
AbbVie: Why Q3 Confirms Its Immunology Dominance (NYSE:ABBV)
Seeking Alpha· 2025-10-31 22:39
公司概况 - 公司拥有超过二十年的投资经验 [2] - 公司采用保守的投资方法 专注于发现被低估的资产 [2] - 公司关注的投资领域包括交易所交易基金、大宗商品、科技及制药公司 [2] 公司战略与使命 - 公司致力于简化投资策略 使其对经验丰富和新入市的投资者都易于理解 [2] - 公司的使命是通过提供发人深省的分析和有见地的观点 为投资社区做出贡献 [2] - 公司旨在揭开投资的复杂性 建立投资者信心 培养能够明智理解市场的投资者社区 [2]
AbbVie: Why Q3 Confirms Its Immunology Dominance
Seeking Alpha· 2025-10-31 22:39
公司概况 - 公司拥有超过20年的投资经验 专注于为个人投资者寻找盈利机会 [2] - 公司采用保守的投资方法 擅长发掘ETF 大宗商品 科技和制药公司领域的被低估资产 [2] - 公司致力于简化投资策略 使其易于被经验丰富的投资者和新手理解与接触 [2] 业务使命与社区参与 - 公司计划通过分享其丰富的知识 为Seeking Alpha社区贡献发人深省的分析和见解 [2] - 公司旨在揭开投资的复杂性 激发读者信心 培养一个能够理性驾驭市场的知情投资者社区 [2] - 公司披露其通过股票所有权 期权或其他衍生工具对ALVO持有有益的长期多头头寸 [3]
Carlyle(CG) - 2025 Q3 - Earnings Call Presentation
2025-10-31 20:30
Carlyle Reports Third Quarter 2025 Financial Results OCTOBER 31, 2025 Carlyle Reports Third Quarter 2025 Financial Results WASHINGTON, D.C. AND NEW YORK – October 31, 2025 – The Carlyle Group Inc. (NASDAQ: CG) today reported its unaudited results for the third quarter ended September 30, 2025. U.S. GAAP Results U.S. GAAP results for Q3 2025 included income before provision for income taxes of $86 million and a margin on income before provision for income taxes of 25.8%. Dividend Conference Call Carlyle will ...
DocuSign: Margin Strength Suggests The Stock Could Mirror Earnings Momentum
Seeking Alpha· 2025-10-30 21:25
Dear Reader,I am a Senior Derivatives Expert with over 10 years of experience in the field of Asset Management, specializing in equity analysis and research, macroeconomics, and risk-managed portfolio construction. My professional background covers both institutional and private client asset management, where I have advised on and implemented multi-asset strategies, but highly focusing on equities and derivatives.As you might be as well, I am a stock market enthusiast. My core passion lies in understanding ...
Merck: Wall Street Surprised By Q3 Strength, Keytruda Sales Surge
Seeking Alpha· 2025-10-30 21:20
It is only with the heart that one can see rightly; what is essential is invisible to the eye.With over two decades of dedicated experience in investment, Allka Research has been a guiding force for individuals seeking lucrative opportunities. Its conservative approach sets it apart, consistently unearthing undervalued assets within the realms of ETFs, commodities, technology, and pharmaceutical companies.Allka Research's journey in the investment landscape is marked by a commitment to delivering substantia ...
Wall Street's Gold Price Forecasts Enable DRDGold To Invest Ambitiously In Gold Projects (Rating Upgrade)
Seeking Alpha· 2025-10-30 20:17
This article upgrades the rating of DRDGOLD Limited ( DRD ), publicly traded on the NYSE under the symbol "DRD," to the current "Buy" rating from the “Hold” previously assigned in ourAlberto holds a Master's degree in Business Economics. During his academic career he acquired an extensive managerial and economic background, with a solid quantitative basis. He covers all sectors and the different types of stocks. Essentially describes a useful investment strategy that fits the profile of any investor, whethe ...
CGCV: A Low-Risk Profile ETF Is Beating The S&P 500
Seeking Alpha· 2025-10-28 18:42
Komal is passionate about finance and the stock market. She enjoys forecasting future market trends using a fundamental and technical approach with a focus on both short- and long-term horizons. She intends to provide unbiased analysis to assist investors in selecting the best investment strategies to stay ahead of the market.Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. ...
Bond Bites: Why Consider Intermediate Bonds Now?
Seeking Alpha· 2025-10-28 01:45
Invesco is an independent investment management firm dedicated to delivering an investment experience that helps people get more out of life.Be the first to know! Sign up for Invesco US Blog and get expert investment views as they post.Disclosure for all Invesco US articles: Before investing, carefully read the prospectus and/or summary prospectus and carefully consider the investment objectives, risks, charges and expenses. The information provided is for educational purposes only and does not constitute a ...
Eli Lilly: Is Another Monster Quarter Coming
Seeking Alpha· 2025-10-26 20:15
公司概况与投资理念 - 公司拥有超过20年的投资经验 专注于为个人投资者发掘投资机会 [1] - 公司的投资风格以保守著称 致力于发现被低估的资产 [1] - 公司的投资领域涵盖交易所交易基金、大宗商品、科技及制药公司 [1] 公司使命与社区贡献 - 公司致力于简化复杂的投资策略 使其对经验丰富和新入市的投资者都易于理解和使用 [1] - 公司通过分享其丰富的知识 旨在为社区提供发人深省的分析和专业的观点 [1] - 公司的目标是帮助读者建立投资信心 培养一个能够理性驾驭市场的投资者社区 [1]
What To Expect From Gilead In Q3 2025
Seeking Alpha· 2025-10-24 22:56
With over two decades of dedicated experience in investment, Allka Research has been a guiding force for individuals seeking lucrative opportunities. Its conservative approach sets it apart, consistently unearthing undervalued assets within the realms of ETFs, commodities, technology, and pharmaceutical companies.Allka Research's journey in the investment landscape is marked by a commitment to delivering substantial returns and strategic insights to its clients. In a world filled with complexities, Allka Re ...